144 related articles for article (PubMed ID: 3030329)
21. Formation of glutathione conjugates during oxidation of eugenol by microsomal fractions of rat liver and lung.
Thompson D; Constantin-Teodosiu D; Egestad B; Mickos H; Moldéus P
Biochem Pharmacol; 1990 May; 39(10):1587-95. PubMed ID: 2337416
[TBL] [Abstract][Full Text] [Related]
22. Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26).
Haim N; Roman J; Nemec J; Sinha BK
Biochem Biophys Res Commun; 1986 Feb; 135(1):215-20. PubMed ID: 3006680
[TBL] [Abstract][Full Text] [Related]
23. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat.
Levine WG; Lu AY
Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393
[TBL] [Abstract][Full Text] [Related]
24. Characterization of an etoposide-glutathione conjugate derived from metabolic activation by human cytochrome p450.
Zheng N; Pang S; Oe T; Felix CA; Wehrli S; Blair IA
Curr Drug Metab; 2006 Dec; 7(8):897-911. PubMed ID: 17168690
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the arachidonic acid and NADPH-dependent microsomal metabolism of naphthalene and 2-methylnaphthalene and the effect of indomethacin on the bronchiolar necrosis.
Buckpitt AR; Bahnson LS; Franklin RB
Biochem Pharmacol; 1986 Feb; 35(4):645-50. PubMed ID: 3081009
[TBL] [Abstract][Full Text] [Related]
26. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N
J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068
[TBL] [Abstract][Full Text] [Related]
27. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
Vyas KP; Kari PH; Prakash SR; Duggan DE
Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
[TBL] [Abstract][Full Text] [Related]
28. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
[TBL] [Abstract][Full Text] [Related]
29. New pathway for retinol metabolism in liver microsomes.
Leo MA; Lieber CS
J Biol Chem; 1985 May; 260(9):5228-31. PubMed ID: 3988751
[TBL] [Abstract][Full Text] [Related]
30. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
Berson A; Wolf C; Chachaty C; Fisch C; Fau D; Eugene D; Loeper J; Gauthier JC; Beaune P; Pompon D
J Pharmacol Exp Ther; 1993 Apr; 265(1):366-72. PubMed ID: 8386241
[TBL] [Abstract][Full Text] [Related]
31. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of the "mixed" cytochrome P-450 inducer hexachlorobenzene by rat liver microsomes.
Stewart FP; Smith AG
Biochem Pharmacol; 1986 Jul; 35(13):2163-70. PubMed ID: 3729973
[TBL] [Abstract][Full Text] [Related]
33. Phencyclidine iminium ion. NADPH-dependent metabolism, covalent binding to macromolecules, and inactivation of cytochrome(s) P-450.
Hoag MK; Trevor AJ; Kalir A; Castagnoli N
Drug Metab Dispos; 1987; 15(4):485-90. PubMed ID: 2888621
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo metabolism of VP 16-213 in the rat.
Van Maanen JM; Van Oort WJ; Pinedo HM
Eur J Cancer Clin Oncol; 1982 Sep; 18(9):885-90. PubMed ID: 6891331
[TBL] [Abstract][Full Text] [Related]
35. Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR Study.
Kalyanaraman B; Nemec J; Sinha BK
Biochemistry; 1989 May; 28(11):4839-46. PubMed ID: 2548593
[TBL] [Abstract][Full Text] [Related]
36. Lipid peroxidation and chemiluminescence during naproxen metabolism in rat liver microsomes.
Yokoyama H; Horie T; Awazu S
Hum Exp Toxicol; 1994 Dec; 13(12):831-8. PubMed ID: 7718302
[TBL] [Abstract][Full Text] [Related]
37. Drug-protein conjugates--XIV. Mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin and hepatotoxin in man.
Maggs JL; Tingle MD; Kitteringham NR; Park BK
Biochem Pharmacol; 1988 Jan; 37(2):303-11. PubMed ID: 3342086
[TBL] [Abstract][Full Text] [Related]
38. Metabolic activation of 2-methylfuran by rat microsomal systems.
Ravindranath V; Boyd MR
Toxicol Appl Pharmacol; 1985 May; 78(3):370-6. PubMed ID: 4049387
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes.
Sawahata T; Neal RA
Mol Pharmacol; 1983 Mar; 23(2):453-60. PubMed ID: 6835203
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of the styrene metabolite 4-vinylphenol by rat and mouse liver and lung.
Carlson GP; Perez Rivera AA; Mantick NA
J Toxicol Environ Health A; 2001 Aug; 63(7):541-51. PubMed ID: 11497334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
